ReviewVaccines2025

Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies.

Sahar Balkhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.